secwatch.observer — SEC 8-K summary
======================================

Issuer:     InMed Pharmaceuticals Inc. (INM)
CIK:        0001728328
Form:       8-K
Filed at:   2024-10-24T23:59:59+00:00
Accession:  0001213900-24-090365
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InMed to participate in Fierce Biotech webinar on Alzheimer's neuroinflammation on Nov 12, 2024
--------------------------------------------------------------------------------

- InMed (Nasdaq: INM) announced participation in Fierce Biotech webinar on November 12, 2024.
- SVP of Preclinical R&D Dr. Eric Hsu will join a panel on neuroinflammation in Alzheimer's disease.
- Webinar topics include latest Alzheimer's research, therapeutic pathways, and drugs in development.
- Panel includes experts from Eli Lilly, Johns Hopkins, Michigan State, and Barrow Neurological Institute.
- No financial results or material business changes were disclosed in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024090365/0001213900-24-090365-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1728328/000121390024090365/ea0218583-8k_inmed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-090365

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer